Shardna has already proven itself for the decisive contribution to the identification and development of diagnostic and pharmacological methods for the multifactorial disease cure and prevention market.
In fact, thanks to the special proprietary techniques of genetic and bioinformatic medical screening, the company is able to analyse the DNA of thousands of people in a very short time. This and the unique characteristics of the population under examination means it can identify the genes related to particular disorders as well as the function of the proteins involved.
